Funding profile · Consumer diagnostics

Million Marker

A Y Combinator company whose balance sheet is almost entirely federal. Nine NIH small business awards totaling $4,780,117 are on record. No Form D has ever been filed.

$4.78MNIH awards on record, FY2022 to FY2026
$150KReported venture funding, Y Combinator, per aggregator
0Form D filings on SEC EDGAR
$399List price of the Exposure Test

Data as of September 22, 2026. Company-reported figures are labeled.

Rounds at a glance

When Round Amount Source of funds Source
2019 Y Combinator, Summer 2019 $150,000 reported Y Combinator Aggregator
To Mar 2022 Early rounds, unnamed Not disclosed Three investors on record Aggregator
May 2022 to Jul 2025 SBIR project ES034312, Phase I then Phase II $2,103,993 NIH NIEHS NIH
Sep 2024 to Jan 2028 SBIR project MD018950, Phase I then Phase II $1,755,511 NIH NIMHD NIH
FY2025 Phase I, ES037592, weight loss and EDCs $306,871 NIH NIEHS NIH
FY2025 Phase I, HL179154, rural PFAS exposure $306,871 NIH NHLBI NIH
FY2026 Phase I, ES036911, male reproductive health $306,871 NIH NIEHS NIH
Any date Regulation D offering None filed Not applicable Nothing found

What the filings show

Million Marker Wellness, Inc. · SEC EDGAR · searched Sep 22, 2026

Form D filings
None
Other filings naming the company
None, including pooled investment vehicles
Implication
Any equity raised was exempt under a route that requires no Form D, or was small enough that none was filed
Entity
Two registrations appear in commercial databases, dated Dec 31, 2017 and May 10, 2019

NIH NIEHS · project ES034312 · May 2022 to Jul 2025

Phase I
1R43ES034312-01, FY2022, $218,790
Phase II year 1
2R44ES034312-02, FY2023, $1,028,322
Phase II year 2
5R44ES034312-03, FY2024, $796,881
Supplement
3R44ES034312-03S1, FY2024, $60,000
Project total
$2,103,993
Principal investigator
Jenna Hua

NIH NIMHD · project MD018950 · Sep 2024 to Jan 2028

Phase I
1R43MD018950-01A1, FY2024, $272,365
Phase II
2R44MD018950-02, FY2026, $1,483,146
Project total
$1,755,511
End date
January 31, 2028
Principal investigator
Jenna Hua

Reading the filings

  1. The federal government is the majority funder.$4,780,117 of NIH money against $150,000 of reported venture funding. If the aggregator figure is complete, about 97 percent of identified capital is non-dilutive. The true equity number is unknown, since no Form D exists to confirm or deny it.
  2. Two projects cleared the Phase II hurdle.ES034312 went from a $218,790 Phase I to $1,028,322 and then $796,881. MD018950 went from $272,365 to $1,483,146, a multiple of 5.4. Phase II conversion is the usual filter in the SBIR program, and this company passed it twice.
  3. Three Phase I awards are identical to the dollar.ES037592, HL179154 and ES036911 are each $306,871, totaling $920,613. Identical amounts across three institutes indicate a standard Phase I budget ceiling rather than three separately negotiated awards.
  4. No Form D is not proof of no equity.Companies that raise under Section 4(a)(2) rather than Regulation D file nothing with the SEC. A Y Combinator company with an aggregator-reported 2022 investment and no filing is consistent with that route.
  5. Revenue is undisclosed.Three list prices are public: $399 for the Exposure Test, $499 for the education program, $999 for the bundled Fertility Kit. Unit volume, repeat rate and gross margin are not. One commercial database estimates annual revenue under $1 million.
  6. The funding runway is dated.The NIEHS ES034312 project period closed July 31, 2025. The NIMHD Phase II runs to January 31, 2028. Beyond that date, nothing on the public record replaces it.

Commercial signals

Signal Detail Source type
Regulatory No FDA 510(k) or premarket approval record. None claimed. Nothing found
Distribution Direct to consumer online, United States only, excluding New York, Rhode Island, Maryland and New Jersey. Company-stated
Demand event Netflix released The Plastic Detox on March 16, 2026. The company sells the test used in the film. Independent
Evidence base Six registered interventional studies, four peer reviewed papers, largest cohort 1,074 participants. Public record
Laboratory The analytical laboratory is never named. Papers describe only a third party. No CLIA certificate number published. Nothing found
Headcount Two at the Y Combinator listing. One commercial database records 18 as of August 2026. Aggregator

What to watch

  • A first Form D. Any priced round after the documentary would be due within 15 days of first sale.
  • Renewal or replacement of federal funding beyond the January 31, 2028 NIMHD end date.
  • Whether the post-documentary demand spike converts into disclosed revenue.
  • Any disclosure naming the laboratory and its CLIA certificate.

The Million Marker story on Healthcare DiscoveryHealthcare Discovery

Related companies

  • Inito: Also in Consumer Health and Wellness. A smartphone connected urine test that reports four reproductive hormones as numbers instead of lines
  • Modern Fertility: Also in Consumer Health and Wellness. A finger prick hormone panel sold to women who were not trying to conceive
  • adyn: Also in Consumer Health and Wellness. A $369 at-home kit that reads DNA from saliva and six hormones from a finger prick, then puts the result in front of a clinician who helps pick a birth control method
  • Legacy: Also in Consumer Health and Wellness. A mail-in kit that tests sperm, and then freezes it, without a clinic visit

Sources

  1. Public recordNIH RePORTER, nine awards to Million Marker Wellness Inc.NIH · FY2022 to FY2026
  2. Public recordSEC EDGAR full text and Form D searchSEC · Sep 22, 2026
  3. Public recordClinicalTrials.gov, six registrationsSponsor Million Marker Wellness, Inc.
  4. AggregatorMillion Marker company profile, funding and entity recordsTracxn · accessed Sep 24, 2026
  5. AggregatorMillion Marker investors and fundinggritt.io · accessed Sep 24, 2026
  6. IndependentThe Plastic Detox documentary examines plastic products and fertilityFood Packaging Forum · Mar 16, 2026
  7. CompanyShop and FAQ pages, pricing and state availabilitymillionmarker.com · Sep 24, 2026
  8. CompanyCompany listing, Summer 2019 batch, team sizeY Combinator · Sep 24, 2026

Compiled from SEC, NIH and other public records and published reports as of September 22, 2026. Form D notices report offerings under Regulation D; the absence of a filing does not establish the absence of a financing. Healthcare Venture Capital Fund holds no position in Million Marker. This page is not an offer to sell or a recommendation to buy any security.